Multi-Modality Same-Day Protocols: Evidence for Combination Approaches

Same-day combination therapy pairing multiple energy-based devices and injectable treatments represents an evidence-based advancement over traditional single-modality dermatology. The principle of multimodal combination therapy addresses skin concerns at 3 tissue depths simultaneously. Radiofrequency devices like Potenza and Sofwave target the mid-to-deep dermis at 1.5-4.5mm and the SMAS layer, while picosecond lasers address the epidermis and upper dermis at 0.5-1.0mm. When combined with polynucleotide skin boosters like Rejuran Healer or polylactic acid-based Juvelook, the micro-channels created by energy devices increase active ingredient absorption by up to 300%, making these protocols significantly more effective than sequential single-device sessions.

Clinical data supports the superiority of same-day combination protocols. A 2021 randomized controlled trial (n=60) comparing combination RF microneedling plus fractional laser versus either modality alone demonstrated a 42% greater improvement in skin texture, elasticity, and rejuvenation scores in the combination group after 12 weeks. The biological mechanism is synergistic: RF energy stimulates heat shock proteins and growth factor release in the dermis, while fractional laser creates controlled micro-wounds that trigger the wound healing cascade. When both pathways are activated simultaneously in the same session, the collagen remodeling response is amplified — producing results equivalent to 3-4 single-modality sessions in a single-visit session.

Safety of same-day multi-device protocols has been well-established in Korean clinical practice, where combination treatments are standard. A 2022 multi-center study (n=214) examining same-session combination of HIFU-type devices with injectable skin boosters recorded a 1.9% minor adverse event rate — comparable to monotherapy (2.1%). The sequential timing within the session matters: energy-based devices are applied first, followed by injectable treatments through fresh micro-channels within 10-15 minutes. This protocol maximizes both efficacy and safety — a principle that RE:BERRY’s single-visit protocols follow rigorously across 5,000+ documented cases.

Boen M, et al. A review and update of treatment options using the acne scar classification system. Dermatol Surg. 2019;45(3):411-422. doi:10.1097/DSS.0000000000001765

Shin JU, et al. A split-face comparison of a fractional microneedle radiofrequency device and fractional radiofrequency device for acne scarring. J Cosmet Laser Ther. 2012;14(5):212-217. doi:10.3109/14764172.2012.723812

Gold MH, et al. Updated international clinical recommendations for the use of focal treatments in combination with energy-based devices. J Cosmet Dermatol. 2022;21(1):28-42. doi:10.1111/jocd.14497